Fulcrum Therapeutics (FULC) Q1 2023 Earnings

15MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.83
-0.69
-0.55
-0.41

Details

Expected EPS
-0.46
Actual EPS
-0.41
Surprise EPS
0.05
Surprise Percent
+10.87%

Description

Fulcrum Therapeutics (FULC) has reported earnings of -0.41 per share for Q1 2023.

0 Comments

Share your thoughts